Join the Class Action Against Neogen Corporation Now
Join the Class Action Against Neogen Corporation
The Gross Law Firm is reaching out to shareholders of Neogen Corporation (NASDAQ: NEOG) following recent developments regarding potential legal actions. Shareholders who purchased NEOG shares during the specified period are encouraged to engage with the firm to discuss their rights and possible lead plaintiff appointments.
Important Information for Shareholders
If you have invested in NEOG between January 5, 2023, and June 3, 2025, it is imperative to connect with the Gross Law Firm about your eligibility in the class action lawsuit. It is important to note that becoming a lead plaintiff is not a prerequisite for participating in any recovery. Timing is critical as the deadline for registration is approaching.
Understanding the Allegations
The class action has arisen from allegations of misleading statements made by Neogen Corporation. According to the filed complaint, the management made several representations regarding the integration with 3M's Food Safety Division, suggesting it was proceeding well. However, once inefficiencies were disclosed, the management allegedly downplayed these issues, leading investors to have a skewed perception of the company's performance and reliability.
Key Dates and Steps
Shareholders must act before the September 16, 2025 deadline to register for the class action. Immediate registration is advised to secure your position. By registering, investors will benefit from portfolio monitoring software, enabling them to receive updates concerning the case's progress and any developments that may occur.
Why Choose Gross Law Firm?
The Gross Law Firm is nationally recognized for its commitment to protecting the interests of investors. Their mission centers around holding corporations accountable for their actions and ensuring that shareholders are not misled. They focus on recovering losses resulting from false statements or the omission of critical information that leads to inflated stock values.
Contact Information
For shareholders wishing to discuss their situation, the Gross Law Firm provides the following contact information:
The Gross Law Firm
15 West 38th Street, 12th Floor
New York, NY, 10018
Phone: (646) 453-8903
Frequently Asked Questions
What is the class action against Neogen Corporation about?
The class action relates to allegations that Neogen Corporation made misleading statements about its integration with the Food Safety Division of 3M.
Who can join the class action?
Shareholders who purchased shares of NEOG between January 5, 2023, and June 3, 2025, are eligible to join the class action.
What is the deadline to register?
The deadline to register for participating in this class action is September 16, 2025.
What are the benefits of joining the class action?
By joining, investors may be able to recover losses incurred due to misleading statements made by Neogen Corporation.
How can I get updates about the class action?
Registered shareholders will receive updates through a monitoring software provided by the Gross Law Firm.
About The Author
Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.